Vision care is undergoing a profound transformation, driven by an aging global population and the "myopia epidemic" among younger generations. The scope of the field has expanded from simple refractive corrections (glasses and contacts) to the management of complex ocular pathologies such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy. One of the most significant topics of discussion is the rise of digital eye strain and its long-term effects on macular health. Clinicians are increasingly focusing on blue-light filtration and the implementation of "orthokeratology"—the use of specially shaped contact lenses worn overnight to reshape the cornea—to slow the progression of myopia in children.
Technologically, the advent of anti-VEGF (Vascular Endothelial Growth Factor) injections has revolutionized the treatment of "wet" AMD, preventing blindness in millions. However, the burden of frequent intraocular injections has prompted research into long-acting delivery implants and gene therapies that could provide a "one-and-done" solution. In the…
